Trade Summary

1 week ago, Barnes Alane P, serving as GC at Biocryst Pharmaceuticals Inc (BCRX), sold 21,773 shares at $7.65 per share, for a total transaction value of $166,563.00. Following this transaction, Barnes Alane P now holds 398,751 shares of BCRX.

This sale represents a 5.00% decrease in Barnes Alane P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 1 day after the trade was made.

Biocryst Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.